The cholecystokinin-B receptor antagonist L-740,093 produces an insurmountable antagonism of CCK-4 stimulated functional response in cells expressing the human CCK-B receptor

Neuropeptides

Volumn 32, Issue 2, 1998, Pages 157-160

  Dunlop, J ^a   Pass, I ^a   Ennis, C ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [5 (3 AZABICYCLO[3.2.2]NON 3 YL) 2,3 DIHYDRO 1 METHYL 2 OXO 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; FURA 2 ACETOXYMETHYL ESTER; RECEPTOR SUBTYPE; TETRAGASTRIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHO CELL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR GENE;

ANIMALIA;

EID: 0031899432     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90031-2     Document Type: Article

References (12)

1. Moran T H, Robinson P H, Goldrich M S, McHugh P R. Brain Res 1986; 362:175-179.
2. Williams J A. Biomed Res 1982; 3:107-115.
3. Bradwejn J, Koszycki D, Couetoux du Terre A et al. Arch Gen Psychiatry 1994; 51:486-493.
4. Hughes J, Boden P, Costall B et al. Proc Natl Acad Sci USA 1990; 87:6728-6732.
5. Lotti V J, Chang R S L. Eur J Pharmacol 1989; 162: 273-280.
6. Patel S, Smith A J Chapman K L et al. Mol Pharmacol 1994; 46: 943-948.
7. Saita Y, Yazawa H, Honma Y, Nishida A, Miyata K, Honda K. Eur J Pharmacol 1994; 269: 249-254.
8. Dunlop J, Brammer N, Evans N, Ennis C. Biochem Pharmacol 1997; (in press).
9. Showell G A, Bourrain S, Neduvelil J G et al. J Med Chem 1994; 37:719-721.
10. Dunlop J, Brammer N, Ennis C. Neuropeptides 1996; 30:359-363.
11. Grynkiewicz G, Poenie M, Tsien R Y. J Biol Chem 1985; 260: 3440-3450.
12. Dunlop J, Zhang Y, Evans N. Peptides 1997; 18:865-868.